Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition

Anna C. Stoll,Christopher J. Kemp,Joseph R. Patterson,Michael Kubik,Nathan Kuhn,Matthew Benskey,Megan F. Duffy,Kelvin C. Luk,Caryl E. Sortwell
DOI: https://doi.org/10.1186/s12974-024-03108-5
IF: 9.3
2024-04-27
Journal of Neuroinflammation
Abstract:Parkinson's disease (PD) is a neurodegenerative disorder that is characterized by the presence of proteinaceous alpha-synuclein (α-syn) inclusions (Lewy bodies), markers of neuroinflammation and the progressive loss of nigrostriatal dopamine (DA) neurons. These pathological features can be recapitulated in vivo using the α-syn preformed fibril (PFF) model of synucleinopathy. We have previously determined that microglia proximal to PFF-induced nigral α-syn inclusions increase in soma size, upregulate major-histocompatibility complex-II (MHC-II) expression, and increase expression of a suite of inflammation-associated transcripts. This microglial response is observed months prior to degeneration, suggesting that microglia reacting to α-syn inclusion may contribute to neurodegeneration and could represent a potential target for novel therapeutics. The goal of this study was to determine whether colony stimulating factor-1 receptor (CSF1R)-mediated microglial depletion impacts the magnitude of α-syn aggregation, nigrostriatal degeneration, or the response of microglial in the context of the α-syn PFF model.
immunology,neurosciences
What problem does this paper attempt to address?